Nitric oxide: A key factor behind the dysfunctionality of endothelial progenitor cells in diabetes mellitus type-2

Cardiovascular Research

Volumn 91, Issue 1, 2011, Pages 9-15

  Hamed, Saher ^a,b   Brenner, Benjamin ^b,c   Roguin, Ariel ^b  

^a Rambam Health Care Campus ^*  (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Diabetes mellitus; EPC; Hyperglycaemia; Hyperlipidaemia; Nitric oxide

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; NITRIC OXIDE;

ATHEROGENESIS; BIOAVAILABILITY; BLOOD VESSEL TONE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ENDOTHELIAL CELLS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPOPROTEINS, LDL; NITRIC OXIDE; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 79958833427     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq412     Document Type: Review

References (71)

1. Kanter JE, Johansson F, LeBoeuf RC, Bornfeldt KE. Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques? Circ Res 2007;100:769-781. (Pubitemid 46555682)
2. Abaci A, Oguzhan A, Kahraman S, Eryol NK, Unal S, Arinç H et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 1999;99:2239-2242. (Pubitemid 29201128)
3. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-967. (Pubitemid 27087709)
4. Lambiase PD, Edwards RJ, Anthopoulos P, Rahman S, Meng YG, Bucknall CA et al. Circulating humoral factors and endothelial progenitor cells in patients with differing coronary collateral support. Circulation 2004;109:2986-2992. (Pubitemid 38808321)
5. Chen YH, Lin SJ, Lin FY,Wu TC, Tsao CR, Huang PH et al. High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes 2007;56:1559-1568.
6. Krankel N, Adams V, Linke A, Gielen S, Erbs S, Lenk K et al. Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells. Arterioscler Thromb Vasc Biol 2005;25:698-703. (Pubitemid 40463856)
7. Callaghan MJ, Ceradini DJ, Gurtner GC. Hyperglycemia-induced reactive oxygen species and impaired endothelial progenitor cell function. Antioxid Redox Signal 2005;7:1476-1482. (Pubitemid 41767982)
8. Ma FX, Zhou B, Chen Z, Ren Q, Lu SH, Sawamura T et al. Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase. J Lipid Res 2006;47:1227-1237. (Pubitemid 43830715)
9. Hamed S, Brenner B, Abassi Z, Aharon A, Daoud D, Roguin A. Hyperglycemia and oxidized-LDL exert a deleterious effect on endothelial progenitor cell migration in type 2 diabetes mellitus. Thromb Res 2010;126:166-174.
10. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003;9:702-712. (Pubitemid 36749219)
11. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000;95:952-958. (Pubitemid 30062717)
12. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004;95:343-353. (Pubitemid 39100452)
13. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004;104:2752-2760. (Pubitemid 39434958)
14. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007;109:1801-1809. (Pubitemid 46348173)
15. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004;24:288-293. (Pubitemid 38197580)
16. Gulati R, Jevremovic D, Peterson TE, Chatterjee S, Shah V, Vile RG et al. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res 2003;93:1023-1025. (Pubitemid 37485031)
17. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000;105:71-77. (Pubitemid 30036389)
18. Timmermans F, Plum J, Yoder MC, Ingram DA, Vandekerckhove B, Case J. Endothelial progenitor cells: identity defined? J Cell Mol Med 2009;13:87-102.
19. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001;7:430-436. (Pubitemid 32298545)
20. Griese DP, Ehsan A, Melo LG, Kong D, Zhang L, Mann MJ et al. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 2003;108: 2710-2715. (Pubitemid 37466815)
21. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89:E1-E7.
22. Hill JM, Zalos G, Halcox JP, Schenke WH,Waclawiw MA, Quyyumi AA et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600. (Pubitemid 36204953)
23. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005;353: 999-1007. (Pubitemid 41262334)
24. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992;35:771-776.
25. Fox CS, Coady S, Sorlie PD, Levy D, Meigs JB, D'Agostino RB Sr et al. Trends in cardiovascular complications of diabetes. JAMA 2004;292:2495-2499. (Pubitemid 39552675)
26. Goldberg RB. Cardiovascular disease in patients who have diabetes. Cardiol Clin 2003; 21:399-413.
27. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation 2003;108:1912-1916. (Pubitemid 37296532)
28. Anderson TJ. Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction. Heart Fail Rev 2003;8:71-86. (Pubitemid 36342291)
29. Quyyumi AA. Circulating endothelial progenitor cells as novel biological determinants of vascular function and risk. Can J Cardiol 2004;20:44B-48B.
30. Landmesser U, Engberding N, Bahlmann FH, Schaefer A, Wiencke A, Heineke A et al. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase. Circulation 2004;110: 1933-1939. (Pubitemid 39331904)
31. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002;106: 2781-2786. (Pubitemid 35396976)
32. Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, Grego F et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 2005;45:1449-1457. (Pubitemid 40615617)
33. Fadini GP, Sartore S, Albiero M, Baesso I, Murphy E, Menegolo M et al. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol 2006;26:2140-2146. (Pubitemid 44253800)
34. Fadini GP, de Kreutzenberg SV, Coracina A, Baesso I, Agostini C, Tiengo A et al. Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk. Eur Heart J 2006; 27:2247-2255. (Pubitemid 44412842)
35. Morello F, Perino A, Hirsch E. Phosphoinositide 3-kinase signalling in the vascular system. Cardiovasc Res 2009;82:261-271.
36. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/ Akt pathway. J Clin Invest 2001;108:391-397. (Pubitemid 32730785)
37. Bahlmann FH, De Groot K, Spandau JM, Landry AL, Hertel B, Duckert T et al. Erythropoietin regulates endothelial progenitor cells. Blood 2004;103:921-926. (Pubitemid 38129551)
38. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999;399:597-601.
39. Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 2003;9:1370-1376. (Pubitemid 37466185)
40. Wattanapitayakul SK, Weinstein DM, Holycross BJ, Bauer JA. Endothelial dysfunction and peroxynitrite formation are early events in angiotensin-induced cardiovascular disorders. FASEB J 2000;14:271-278. (Pubitemid 30086064)
41. Ozuyaman B, Ebner P, Niesler U, Ziemann J, Kleinbongard P, Jax T et al. Nitric oxide differentially regulates proliferation and mobilization of endothelial progenitor cells but not of hematopoietic stem cells. Thromb Haemost 2005;94:770-772. (Pubitemid 41489235)
42. Boger RH, Bode-Boger SM. Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases. Semin Thromb Hemost 2000;26:539-545.
43. Thum T, Tsikas D, Stein S, Schultheiss M, Eigenthaler M, Anker SD et al. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J Am Coll Cardiol 2005;46: 1693-1701. (Pubitemid 41531624)
44. Avogaro A, Toffolo G, Kiwanuka E, de Kreutzenberg SV, Tessari P, Cobelli C. L-Arginine-nitric oxide kinetics in normal and type 2 diabetic subjects: a stable-labelled 15N arginine approach. Diabetes 2003;52:795-802. (Pubitemid 36323588)
45. Bauersachs J, Schäfer A. Tetrahydrobiopterin and eNOS dimer/monomer ratio-a clue to eNOS uncoupling in diabetes? Cardiovasc Res 2005;65:768-769. (Pubitemid 40249721)
46. Segal MS, Shah R, Afzal A, Perrault CM, Chang K, Schuler A et al. Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes. Diabetes 2006;55:102-109. (Pubitemid 43343304)
47. Gallagher KA, Liu ZJ, Xiao M, Chen H, Goldstein LJ, Buerk DG et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest 2007;117: 1249-1259. (Pubitemid 46718413)
48. Sorrentino SA, Bahlmann FH, Besler C, Müller M, Schulz S, Kirchhoff N et al. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus. Circulation 2007;116:163-173.
49. Hamed S, Brenner B, Aharon A, Daoud D, Roguin A. Nitric oxide and superoxide dismutase modulate endothelial progenitor cell function in type 2 diabetes mellitus. Cardiovasc Diabetol 2009;8:56.
50. Niwano K, Arai M, Tomaru K, Uchiyama T, Ohyama Y, Kurabayashi M. Transcriptional stimulation of the eNOS gene by the stable prostacyclin analogue beraprost is mediated through cAMP-responsive element in vascular endothelial cells: close link between PGI2 signal and NO pathways. Circ Res 2003;93:523-530. (Pubitemid 37163232)
51. Miyahara Y, Ohnishi S, Obata H, Ishino K, Sano S, Mori H et al. Beraprost sodium enhances neovascularization in ischemic myocardium by mobilizing bone marrow cells in rats. Biochem Biophys Res Commun 2006;349:1242-1249. (Pubitemid 44419611)
52. Di Stefano R, Barsotti MC, Melillo E, Iorio M, Santoni T, Armani C et al. The prostacyclin analogue iloprost increases circulating endothelial progenitor cells in patients with critical limb ischemia. Thromb Haemost 2008;100:871-877.
53. Kawabe J, Yuhki K, Okada M, Kanno T, Yamauchi A, Tashiro N et al. Prostaglandin I2 promotes recruitment of endothelial progenitor cells and limits vascular remodeling. Arterioscler Thromb Vasc Biol 2010;30:464-470.
54. Kuki S, Imanishi T, Kobayashi K, Matsuo Y, Obana M, Akasaka T. Hyperglycemia accelerated endothelial progenitor cell senescence via the activation of p38 mitogenactivated protein kinase. Circ J 2006;70:1076-1081. (Pubitemid 44161749)
55. Thum T, Fraccarollo D, Schultheiss M, Froese S, Galuppo P, Widder JD et al. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 2007;56:666-674. (Pubitemid 46348461)
56. Cohen RA, Tong X. Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease. J Cardiovasc Pharmacol 2010;55:308-316.
57. Galasso G, Schiekofer S, Sato K, Shibata R, Handy DE, Ouchi N et al. Impaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction. Circ Res 2006;98:254-261.
58. Giansante C, Fiotti N. Insights into human hypertension: the role of endothelial dysfunction. J Hum Hypertens 2006;20:725-726. (Pubitemid 44430669)
59. Landmesser U, Merten R, Spiekermann S, Büttner K, Drexler H, Hornig B. Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation 2000; 101:2264-2270. (Pubitemid 30317128)
60. Ceradini DJ, Yao D, Grogan RH, Callaghan MJ, Edelstein D, Brownlee M et al. Decreasing intracellular superoxide corrects defective ischemia-induced new vessel formation in diabetic mice. J Biol Chem 2008;283:10930-10938.
61. Di Stefano V, Cencioni C, Zaccagnini G, Magenta A, Capogrossi MC, Martelli F. p66ShcA modulates oxidative stress and survival of endothelial progenitor cells in response to high glucose. Cardiovasc Res 2009;82:421-429.
62. Dernbach E, Urbich C, Brandes RP, Hofmann WK, Zeiher AM, Dimmeler S. Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood 2004;104:3591-3597. (Pubitemid 39564432)
63. He T, Peterson TE, Holmuhamedov EL, Terzic A, Caplice NM, Oberley LW et al. Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase. Arterioscler Thromb Vasc Biol 2004;24:2021-2027. (Pubitemid 39482424)
64. Ohshima M, Li TS, Kubo M, Qin SL, Hamano K. Antioxidant therapy attenuates diabetes-related impairment of bone marrow stem cells. Circ J 2009;73:162-166.
65. Tao J, Yang Z, Wang JM, Wang LC, Luo CF, Tang AL et al. Shear stress increases Cu/Zn SOD activity and mRNA expression in human endothelial progenitor cells. J Hum Hypertens 2007;21:353-358. (Pubitemid 46637941)
66. Lamharzi N, Renard CB, Kramer F, Pennathur S, Heinecke JW, Chait A et al. Hyperlipidemia in concert with hyperglycemia stimulates the proliferation of macrophages in atherosclerotic lesions: potential role of glucose-oxidized LDL. Diabetes 2004;53: 3217-3225. (Pubitemid 39564498)
67. Caballero AE. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease. Obes Res 2003;11:1278-1289. (Pubitemid 41127348)
68. Shimada K, Mokuno H, Matsunaga E, Miyazaki T, Sumiyoshi K, Miyauchi K et al. Circulating oxidized low-density lipoprotein is an independent predictor for cardiac event in patients with coronary artery disease. Atherosclerosis 2004;174:343-347. (Pubitemid 38597092)
69. Xu Q, Zhang Z, Davison F, Hu Y. Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in ApoE-deficient mice. Circ Res 2003; 93:e76-e86.
70. Patschan D, Patschan S, Henze E,Wessels JT, Koziolek M, Müller GA. LDL lipid apheresis rapidly increases peripheral endothelial progenitor cell competence. J Clin Apher 2009;24:180-185.
71. Imanishi T, Hano T, Sawamura T, Nishio I. Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clin Exp Pharmacol Physiol 2004;31:407-413. (Pubitemid 39044118)